Programme subject to change. All session times are listed in Europe/Rome Time Zone (CET) (UTC+1).
-
Friday, Nov 13th
10:30 - 12:00 CETMaster Class: Testicular Cancer 2026 - Precision, Pragmatism, and the Long GameCo-Chair: – University of California San Diego
Co-Chair: – Hassan II University Hospital
-
Friday, Nov 13th
10:30 - 10:38 CETGuideline-directed Care of Patients with Gcts: What’s New?
-
Friday, Nov 13th
10:38 - 10:46 CETStage I Seminoma and NSGCT: How Little Is Enough? – Christian Fankhauser (Switzerland) – 8 mins
1. key focus:
1. surveillance vs Adjuvant therapy
2. psychosocial and Fertility outcomes
3. shared Decision-making Frameworks
-
Friday, Nov 13th
10:46 - 10:54 CETBiomarkers that matter: miRNA-371 and ctDNA ?
-
Friday, Nov 13th
10:54 - 11:02 CETStage II Seminoma: Modern AlgorithmsSpeaker: – University of California San Diego
-
Friday, Nov 13th
11:02 - 11:10 CETPrimary RPLND for Marker-positive NSGCT: Ready for Prime Time?
-
Friday, Nov 13th
11:10 - 11:18 CETRobotic RPLND: Progress and Pitfalls
-
Friday, Nov 13th
11:18 - 11:26 CETSurvivorship Is the Endpoint: Long-term Toxicity, Fertility, and Quality of LifeSpeaker: – Hassan II University Hospital
-
Friday, Nov 13th
11:26 - 11:34 CETOptimal Approach to Post-chemotherapy RPLNDSpeaker: – University Hospital Cologne
-
Friday, Nov 13th
11:34 - 12:00 CETCase-based management of GCTsModerator: – Tata Memorial Hospital, Homi Bhabha National Institute
Panelist: – Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel
Panelist: